Kératite épithéliale à herpès simplex et lentilles de contact

Auteurs-es

  • Ziqing Li Université de Waterloo

DOI :

https://doi.org/10.15353/cjo.v86i3.5612

Mots-clés :

Kératite herpétique, lentilles de contact, cellules de Langerhans, kératite épithéliale à herpès simplex

Résumé

La kératite herpétique est une infection oculaire causée par la réactivation du virus de l’herpès simplex (VHS). Cette infection, si elle n’est pas traitée rapidement, peut entraîner une diminution de l’acuité visuelle, voire un risque de cécité de l’œil atteint. Les caractéristiques de cette infection qui peuvent être préjudiciables à la vision sont principalement la formation de cicatrices et l’opacification de la cornée. Une femme de 22 ans, qui portait des lentilles de contact et qui était par ailleurs en bonne santé, a consulté un médecin en raison de douleurs et de rougeurs oculaires, ainsi que d’yeux photophobiques. Lors de l’examen, on a découvert un ulcère dendritique à l’œil droit, accompagné d’une kératopathie toxique aux deux yeux. Cette affection s’explique par l’utilisation d’une solution de nettoyage dans laquelle la patiente avait rangé ses lentilles de contact avant de les porter. Le schéma thérapeutique prescrit consistait en un traitement par le valacyclovir par voie orale et une lubrification oculaire topique. La perturbation des barrières immunologiques naturelles de l’hôte, exacerbée par la manipulation sous-optimale des lentilles de contact, a ouvert la voie à une ulcération dendritique ultérieure. Cette étude de cas montre comment une manipulation inadéquate des lentilles de contact peut compromettre la santé cornéenne et réactiver le VHS.

Références

1. Grinde B. Herpesviruses: latency and reactivation–viral strategies and host response. J oral microbiol. 2013;5(1):22766. doi:10.3402/jom.v5i0.22766

2. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. Nov 2007;57(5):737-63; quiz 764-6. doi:10.1016/j.jaad.2007.06.027

3. AlMukdad S, Harfouche M, Farooqui US, Aldos L, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 1 in Canada: systematic review, meta-analyses, and meta-regressions. Front Public Health. 2023;11:1118249. doi:10.3389/fpubh.2023.1118249

4. AlMukdad S, Farooqui US, Harfouche M, Aldos L, Abu-Raddad LJ. Epidemiology of Herpes Simplex Virus Type 2 in Canada, Australia, and New Zealand: Systematic Review, Meta-Analyses, and Meta-Regressions. Sex Transm Dis. Jun 1 2022;49(6):403-413. doi:10.1097/OLQ.0000000000001612

5. Tran T, Druce J, Catton M, Kelly H, Birch C. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex transm infect. 2004;80(4):277-279.

6. Reynaud C, Rousseau A, Kaswin G, M'Garrech M, Barreau E, Labetoulle M. Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis. Ophthalmol. Feb 2017;124(2):160-169. doi:10.1016/j.ophtha.2016.10.001

7. Stoeger T, Adler H. “Novel” triggers of herpesvirus reactivation and their potential health relevance. Front Microbiol. 2019;9:3207. doi:10.3389/fmicb.2018.03207

8. Efron N, Jones L, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci. Oct 18 2013;54(11):TFOS98-TFOS122. doi:10.1167/iovs.13-13187

9. Ayoade F, Kumar S. Varicella-Zoster Virus (Chickenpox). In: StatPearls, ed. StatPearls [Internet]. StatPearls Publishing; 2024 Jan.

10. Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol. Mar 2014;12(3):197-210. doi:10.1038/nrmicro3215

11. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. May 2010;48 Suppl 1(Suppl 1):S2-7. doi:10.1016/S1386-6532(10)70002-0

12. Kennedy PGE. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses. Jul 30 2023;15(8)doi:10.3390/v15081663

13. Minor M, Payne E. Herpes Zoster Ophthalmicus. In: StatPearls, ed. StatPearls [Internet]. StatPearls Publishing; 2024 Jan.

14. Nagel MA, Gilden D. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol. Aug 2013;15(4):439-53. doi:10.1007/s11940-013-0246-5

15. Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Med Hypothesis Discov Innov Ophthalmol. Winter 2015;4(4):142-156.

16. Schmader KE, Dworkin RH. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention. 2017:25-44.

17. Jackson AC. Viral infections of the human nervous system. Springer Science & Business Media; 2012.

18. Borkar DS, Tham VM, Esterberg E, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmol. Mar 2013;120(3):451-456. doi:10.1016/j.ophtha.2012.09.007

19. Kanski JJ, Bowling B. Kanski's clinical ophthalmology e-book: a systematic approach. Elsevier Health Sciences; 2015.

20. Liesegang TJ. Contact lens-related microbial keratitis: Part I: Epidemiology. Cornea. Mar 1997;16(2):125-31.

21. Hatami H, Ghaffari Jolfayi A, Ebrahimi A, Golmohammadi S, Zangiabadian M, Nasiri MJ. Contact Lens Associated Bacterial Keratitis: Common Organisms, Antibiotic Therapy, and Global Resistance Trends: A Systematic Review. Front Ophthalmol. 2021;1:759271.

22. Musa F, Tailor R, Gao A, Hutley E, Rauz S, Scott RA. Contact lens-related microbial keratitis in deployed British military personnel. Br J Ophthalmol. Aug 2010;94(8):988-93. doi:10.1136/bjo.2009.161430

23. Gurnani B, Kaur K. Bacterial Keratitis. StatPearls [Internet]. StatPearls Publishing; 2023.

24. Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog. Mar 2017;104:97-109. doi:10.1016/j.micpath.2016.12.013

25. Szentmáry N, Daas L, Shi L, et al. Acanthamoeba keratitis–Clinical signs, differential diagnosis and treatment. J curr ophthalmol. 2019;31(1):16-23.

26. de Lacerda AG, Lira M. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthal Physiol Opt. Jan 2021;41(1):116-135. doi:10.1111/opo.12752

27. Ibrahim YW, Boase DL, Cree IA. How could contact lens wearers be at risk of Acanthamoeba infection? A review. J Optom. 2009;2(2):60-66.

28. de Paiva CS, St Leger AJ, Caspi RR. Mucosal immunology of the ocular surface. Mucosal Immunol. Jun 2022;15(6):1143-1157. doi:10.1038/s41385-022-00551-6

29. Somani SN, Ronquillo Y, Moshirfar M. Acanthamoeba Keratitis. StatPearls. 2023.

30. Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol. 2017;11:185-191. doi:10.2147/OPTH.S80475

31. Liesegang TJ. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982. Trans Am Ophthalmol Soc. 1988;86:688-724.

32. Whitley R, Kimberlin D, Prober C. Pathogenesis and disease. In: Arvin A, Campadelli-Fiume G, Mocarski E, eds. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press; 2007:chap 32.

33. Fernandez-Obregon AC, Shah D, Howell AI, et al. Challenges in anti-infective therapy for skin conditions: part 1. Expert Rev Dermatol. 2008;3(3):367-394.

34. James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. May 1 2020;98(5):315-329. doi:10.2471/BLT.19.237149

35. Chew T, Taylor KE, Mossman KL. Innate and adaptive immune responses to herpes simplex virus. Viruses. Dec 2009;1(3):979-1002. doi:10.3390/v1030979

36. Mustafa M, Illzam E, Muniandy R, Sharifah A, Nang M, Ramesh B. Herpes simplex virus infections, Pathophysiology and Management. IOSR J dent med sci. 2016;15(07):85-91.

37. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. The J infectious dis. 2000;181(4):1454-1457.

38. Ahmad B, Patel B. Herpes Simplex Keratitis. StatPearls [Internet]. StatPearls Publishing; 2023.

39. Bagga B, Kate A, Joseph J, Dave V. Herpes simplex infection of the eye: an introduction. Community Eye Health. 2020;33(108):68-70.

40. Kanukollu VM, Patel BC. Herpes simplex ophthalmicus. StatsPearls [Internet]. StatPearls Publishing; 2023 Apr 17.

41. Hill GM, Ku ES, Dwarakanathan S. Herpes simplex keratitis. Disease-a-Month. 2014;60(6):239-246.

42. Chaloulis SK, Mousteris G, Tsaousis KT. Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update. Trop Med Infect Dis. Jun 7 2022;7(6)doi:10.3390/tropicalmed7060092

43. McCormick I, James C, Welton NJ, et al. Incidence of Herpes Simplex Virus Keratitis and Other Ocular Disease: Global Review and Estimates. Ophthal Epidemiol. Aug 2022;29(4):353-362. doi:10.1080/09286586.2021.1962919

44. Farhatullah S, Kaza S, Athmanathan S, Garg P, Reddy SB, Sharma S. Diagnosis of herpes simplex virus-1 keratitis using Giemsa stain, immunofluorescence assay, and polymerase chain reaction assay on corneal scrapings. Br J Ophthalmol. Jan 2004;88(1):142-4. doi:10.1136/bjo.88.1.142

45. Subhan S, Jose RJ, Duggirala A, et al. Diagnosis of herpes simplex virus-1 keratitis: comparison of Giemsa stain, immunofluorescence assay and polymerase chain reaction. Curr Eye Res. Aug-Sep 2004;29(2-3):209-13. doi:10.1080/02713680490504911

46. Cope JR, Konne NM, Jacobs DS, et al. Corneal infections associated with sleeping in contact lenses—six cases, United States, 2016–2018. Morbidity and Mortality Weekly Report. 2018;67(32):877.

47. Fleiszig SM, Kroken AR, Nieto V, et al. Contact lens-related corneal infection: Intrinsic resistance and its compromise. Prog retinal eye res. 2020;76:100804. doi:10.1016/j.preteyeres.2019.100804

48. Barba Gallardo LF, Muñoz Ortega MH, Ventura Juarez J, et al. Extended low oxygen transmissibility contact lens use induces alterations in the concentration of proinflammatory cytokines, enzymes and electrolytes in tear fluid. Exp Ther Med. 2018;15(5):4291-4297. doi:10.3892/etm.2018.5989

49. Boost M, Cho P, Wang Z. Disturbing the balance: effect of contact lens use on the ocular proteome and microbiome. Clin exp optom. 2017;100(5):459-472. doi:10.1111/cxo.12582

50. Akpek E, Gottsch J. Immune defense at the ocular surface. Eye. 2003;17(8):949-956.

51. Pearlman E, Sun Y, Roy S, et al. Host defense at the ocular surface. Internat rev immunol. 2013;32(1):4-18.

52. Liesegang TJ. Physiologic changes of the cornea with contact lens wear. CLAO J. Jan 2002;28(1):12-27.

53. Martin XY, Safran AB. Corneal hypoesthesia. Surv ophthalmol. 1988;33(1):28-40. doi:10.1016/0039-6257(88)90070-7

54. Yang AY, Chow J, Liu J. Focus: sensory biology and pain: corneal innervation and sensation: the eye and beyond. The Yale j biol med. 2018;91(1):13.

55. Lens Cleaning Solution. 2009:2. Material Safety Data Sheet. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.mccsd.net/cms/lib/NY02208580/Centricity/Shared/Material%20Safety%20Data%20Sheets%20_MSDS_/MSDS%20Sheets_Lens_Cleaning_Solution_406_00.pdf

56. Lee J, Jun JH. Ocular chemical burn associated with gel type alcohol-based hand sanitizer: A case report. Medicine (Baltimore). Oct 22 2021;100(42):e27292. doi:10.1097/MD.0000000000027292

57. Oh JY, Yu JM, Ko JH. Analysis of ethanol effects on corneal epithelium. Invest Ophthalmol Vis Sci. Jun 4 2013;54(6):3852-6. doi:10.1167/iovs.13-11717

58. Hamrah P, Pavan-Langston D, Dana R. Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future. Internat ophthalmol clin. 2009;49(1):53. doi:10.1097/IIO.0b013e3181924dd8

59. Jager MJ, Atherton S, Bradley D, Streilein JW. Herpetic stromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea. Curr Eye Res. 1991;10 Suppl:69-73. doi:10.3109/02713689109020360

60. Alzahrani Y, Pritchard N, Efron N. Changes in corneal Langerhans cell density during the first few hours of contact lens wear. Contact Lens Ant Eye. 2016;39(4):307-310. doi:10.1016/j.clae.2016.02.008

61. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. Jan 9 2015;1(1):CD002898. doi:10.1002/14651858.CD002898.pub5

62. White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline. Hoskins Center for Quality Eye Care and American Academy of Ophthalmology Website https://www.aao.org/education/clinical-statement/herpes-simplex-virus-keratitis-treatment-guideline

63. Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database Syst Rev. Nov 14 2016;11(11):CD011503. doi:10.1002/14651858.CD011503.pub2

64. Koganti R, Yadavalli T, Shukla D. Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections. Microorganisms. Oct 10 2019;7(10)doi:10.3390/microorganisms7100429

65. Tsatsos M, MacGregor C, Athanasiadis I, et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment. Clin Exp Ophthalmol. Dec 2017;45(9):932. doi:10.1111/ceo.12991

66. Keegan P. Data from: Summary of Review. 2015. U.S Food and Drug Administration

67. Administration USFaD. Data from: Drug Approval Package. 2010. U.S. Food and Drug Administration.

68. Shearer DR, Bourne WM. Severe ocular anterior segment ischemia after long-term trifluridine treatment for presumed herpetic keratitis. Am J Ophthalmol. Mar 15 1990;109(3):346-7. doi:10.1016/s0002-9394(14)74564-7

69. Hernandez-Camarena JC, Suh LH. Severe Anterior Segment Toxicity Associated to Long-Term Use of Topical Trifluridine. JSM Ophthalmol. 07 March 2014;2(3):1023. doi:10.47739/2333-6447/1023

70. Laboratoires Thea. Eyezirgan. Clermont-Ferrand, France2022.

71. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med. Jul 30 1998;339(5):300-6. doi:10.1056/NEJM199807303390503

72. Group HEDS. Predictors of recurrent herpes simplex virus keratitis. Cornea. 2001;20(2):123-128.

73. Mucci JJ, Utz VM, Galor A, Feuer W, Jeng BH. Recurrence rates of herpes simplex virus keratitis in contact lens and non-contact lens wearers. Eye contact lens. 2009;35(4):185-187. doi:10.1097/ICL.0b013e3181a9d788

Publié-e

2024-09-18

Comment citer

Li, Z. (2024). Kératite épithéliale à herpès simplex et lentilles de contact . Canadian Journal of Optometry, 86(3), 29–50. https://doi.org/10.15353/cjo.v86i3.5612

Numéro

Rubrique

Rapports de cas